Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 7/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 7/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 6/20 | 0.47 |
| ▸ | MAPT | P10636 | 5/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 5/20 | 0.47 |
| ▸ | ABCG2 | Q9UNQ0 | 4/20 | 0.47 |
| ▸ | HPGD | P15428 | 4/20 | 0.47 |
| ▸ | ALOX15 | P16050 | 4/20 | 0.47 |
| ▸ | TP53 | P04637 | 3/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.47 |
| ▸ | LMNA | P02545 | 3/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.46 |
| ▸ | NFKB1 | P19838 | 4/20 | 0.46 |
| ▸ | NFKB2 | Q00653 | 3/20 | 0.46 |
| ▸ | RELA | Q04206 | 3/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.46 |
| ▸ | NR1H4 | Q96RI1 | 2/20 | 0.46 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.46 |
| ▸ | CTSL | P07711 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27676946 | 0.90 | CAPN1 (0.51) | MEN1KMT2ACYP3A4MAPTMAPK1 | |
| SCHEMBL2023110 | 0.84 | CYP3A4 (0.47) | MEN1KMT2ACYP3A4MAPTMAPK1 | |
| SCHEMBL4655610 | 0.81 | ABCG2 (0.52) | MEN1KMT2ACYP3A4MAPTMAPK1 | |
| SCHEMBL5084410 | 0.81 | MAOA (0.45) | MEN1KMT2ACYP3A4MAPTMAPK1 | |
| SCHEMBL8115829 | 0.80 | AURKA (0.40) | CYP3A4ABCG2NFKB1NFKB2RELA | |
| SCHEMBL15467475 | 0.79 | MEN1 (0.47) | MEN1KMT2ACYP3A4MAPTMAPK1 | |
| SCHEMBL2023335 | 0.79 | MEN1 (0.47) | MEN1KMT2ACYP3A4MAPTMAPK1 | |
| SCHEMBL30254953 | 0.77 | MAPT (0.42) | MEN1KMT2ACYP3A4MAPTABCG2 | |
| SCHEMBL29267639 | 0.76 | AURKA (0.50) | MEN1KMT2ACYP3A4MAPTABCG2 | |
| SCHEMBL5127011 | 0.76 | ALDH1A1 (0.34) | MAPK1HPGDALOX15ALDH1A1HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230045522-A1 | COMPOSITIONS AND METHODS TO MODULATE GLUCOSE HOMEOSTASIS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2023-02-09 | — | — | US | claimed |
| WO-2021113473-A1 | COMPOSITIONS AND METHODS TO MODULATE GLUCOSE HOMEOSTASIS | THE BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND AGRICULTURAL AND MECHANICAL COLLEGE (US) | 2021-06-10 | — | — | WO | claimed |
| EP-1996212-A2 | COMPOUNDS FROM AN EXTRACT OF ARTEMISIA AND METHODS FOR TREATING DISORDERS | Rutgers, The State University of New Jersey (US) | 2008-12-03 | — | — | EP | claimed |
| WO-2007109217-A2 | COMPOUNDS FROM AN EXTRACT OF ARTEMISIA AND METHODS FOR TREATING DISORDERS | RUTGERS, THE STATES UNIVERSITY OF NEW JERSEY (US) | 2007-09-27 | — | — | WO | claimed |
| US-20070224301-A1 | Compounds from an extract of Artemisia and methods for treating disorders | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY | 2007-09-27 | — | — | US | claimed |
| US-20230045522-A1 | COMPOSITIONS AND METHODS TO MODULATE GLUCOSE HOMEOSTASIS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2023-02-09 | — | — | US | disclosed |
| WO-2021113473-A1 | COMPOSITIONS AND METHODS TO MODULATE GLUCOSE HOMEOSTASIS | THE BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND AGRICULTURAL AND MECHANICAL COLLEGE (US) | 2021-06-10 | — | — | WO | disclosed |
| US-20140135359-A1 | METHODS OF DESIGNING, PREPARING, AND USING NOVEL PROTONOPHORES | MARTINEAU LOUIS C (CA) | 2014-05-15 | — | — | US | disclosed |
| EP-1996212-A2 | COMPOUNDS FROM AN EXTRACT OF ARTEMISIA AND METHODS FOR TREATING DISORDERS | Rutgers, The State University of New Jersey (US) | 2008-12-03 | — | — | EP | disclosed |
| EP-1996212-A2 | COMPOUNDS FROM AN EXTRACT OF ARTEMISIA AND METHODS FOR TREATING DISORDERS | Rutgers, The State University of New Jersey (US) | 2008-12-03 | — | — | EP | disclosed |
| WO-2007109217-A3 | COMPOUNDS FROM AN EXTRACT OF ARTEMISIA AND METHODS FOR TREATING DISORDERS | RUTGERS THE STATES UNIVERSITY (US) | 2008-01-17 | — | — | WO | disclosed |
| WO-2007109217-A2 | COMPOUNDS FROM AN EXTRACT OF ARTEMISIA AND METHODS FOR TREATING DISORDERS | RUTGERS, THE STATES UNIVERSITY OF NEW JERSEY (US) | 2007-09-27 | — | — | WO | disclosed |
| WO-2007109217-A2 | COMPOUNDS FROM AN EXTRACT OF ARTEMISIA AND METHODS FOR TREATING DISORDERS | RUTGERS, THE STATES UNIVERSITY OF NEW JERSEY (US) | 2007-09-27 | — | — | WO | disclosed |
| US-20070224301-A1 | Compounds from an extract of Artemisia and methods for treating disorders | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY | 2007-09-27 | — | — | US | disclosed |
| US-20070224301-A1 | Compounds from an extract of Artemisia and methods for treating disorders | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY | 2007-09-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070224301-A1 | Compounds from an extract of Artemisia and methods for treating disorders | PDK2, PCK2, DUSP2 | MEN1 3925/4885KMT2A 1873/4885CYP3A4 2330/4885 |
| US-20140135359-A1 | METHODS OF DESIGNING, PREPARING, AND USING NOVEL PROTONOPHORES | UQCRC2, UQCRC1, TIMM50 | MEN1 1092/4885KMT2A 3551/4885CYP3A4 1091/4885 |
| US-20230045522-A1 | COMPOSITIONS AND METHODS TO MODULATE GLUCOSE HOMEOSTASIS | GCKR, G6PC1, GPR119 | MEN1 1345/4885KMT2A 3878/4885CYP3A4 4265/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.